Birchview Capital’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-20,000
| Closed | -$117K | – | 57 |
|
|
2022
Q4 | $117K | Hold |
20,000
| – | – | 0.08% | 52 |
|
|
2022
Q3 | $134K | Hold |
20,000
| – | – | 0.09% | 53 |
|
|
2022
Q2 | $84K | Hold |
20,000
| – | – | 0.06% | 55 |
|
|
2022
Q1 | $67K | Hold |
20,000
| – | – | 0.05% | 62 |
|
|
2021
Q4 | $63K | Hold |
20,000
| – | – | 0.04% | 66 |
|
|
2021
Q3 | $65K | Hold |
20,000
| – | – | 0.04% | 64 |
|
|
2021
Q2 | $84K | Hold |
20,000
| – | – | 0.05% | 62 |
|
|
2021
Q1 | $100K | Buy |
+20,000
| New | +$100K | 0.06% | 54 |
|